(Q34248241)

31 July 2017

title

Cerebrospinal fluid biomarkers for dementia with lewy bodies (English)

1 reference

31 July 2017

0 references

0 references

0 references

Elizabeta B Mukaetova-Ladinska

series ordinal

1

1 reference

31 July 2017

Rachael Monteith

series ordinal

2

1 reference

31 July 2017

Elaine K Perry

series ordinal

3

1 reference

31 July 2017

publication date

17 October 2010

1 reference

International journal of Alzheimer's disease

31 July 2017

published in

1 reference

31 July 2017

volume

2010

1 reference

31 July 2017

page(s)

536538

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Cystatin C protects neuronal cells from amyloid-beta-induced toxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

The role of DAT-SPECT in movement disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Size frequency distribution of the beta-amyloid (abeta) deposits in dementia with Lewy bodies with associated Alzheimer's disease pathology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Education differences in life expectancy with cognitive impairment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Cardiovascular disease and risk factors in Asia: a selected review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

CSF neurofilament proteins in the differential diagnosis of dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Axonal transport and Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Pathophysiology of synuclein aggregation in Lewy body disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Alpha-synuclein expression in the developing human brain

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Proteome analysis of human substantia nigra in Parkinson's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Psychotic symptoms in Parkinson's disease: pathophysiology and management

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Familial occurrence of dementia with Lewy bodies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

alpha-Synuclein locus triplication causes Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Aggregation and neurotoxicity of alpha-synuclein and related peptides

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

alpha-Synuclein is phosphorylated in synucleinopathy lesions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Dementia with Lewy bodies: diagnosis and management

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

The interpretation of diagnostic tests

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Monitoring pathological assembly of tau and beta-amyloid proteins in Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965495

What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?

28 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Clinical and quantitative pathologic correlates of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Reduced CSF CART in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Neuropathologic findings of dementia with lewy bodies (DLB) in a population-based Vantaa 85+ study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

An aberrant protein complex in CSF as a biomarker of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F536538

Elemental profile of cerebrospinal fluid in patients with Parkinson's disease

21 January 2018

1 reference

12 December 2020

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

12 December 2020

1 reference

12 December 2020

Validity of clinical criteria for the diagnosis of dementia with Lewy bodies

1 reference

12 December 2020

Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution

1 reference

12 December 2020

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

1 reference

12 December 2020

In biomarkers we trust?

1 reference

12 December 2020

Alpha-synuclein inclusions in Alzheimer and Lewy body diseases

1 reference

12 December 2020

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease

1 reference

12 December 2020

Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders

1 reference

12 December 2020

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

12 December 2020

The CST3 BB Genotype and Low Cystatin C Cerebrospinal Fluid Levels are Associated with Dementia in Lewy Body Disease

1 reference

12 December 2020

1 reference

12 December 2020

α-Synuclein multiplication analysis in Italian familial Parkinson disease

1 reference

12 December 2020

Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors

1 reference

12 December 2020

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

1 reference

12 December 2020

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

1 reference

12 December 2020

Identifiers

DOI

10.4061/2010/536538

1 reference

31 July 2017

1 reference

31 July 2017

1 reference